DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
Bispecific antibodies can bind to two distinct targets though the fusion of two different Fv regions. In this study, the authors develop DutaFabs that present two separated and independent antigen binding sites within the same Fv region, giving rise to bispecific Fab fragments.
Enregistré dans:
Auteurs principaux: | Roland Beckmann, Kristian Jensen, Sebastian Fenn, Janina Speck, Katrin Krause, Anastasia Meier, Melanie Röth, Sascha Fauser, Raymond Kimbung, Derek T. Logan, Martin Steegmaier, Hubert Kettenberger |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/70c0f8f5eaae4c48be3ad457ee0a7a4b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of DNA sequence of Fab fragment on yield characteristics and cell growth of E. coli
par: Antti Kulmala, et autres
Publié: (2017) -
Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
par: Duan D, et autres
Publié: (2018) -
The Functional Assessment of Balance in Concussion (FAB-C) Battery
par: Thaer Manaseer, et autres
Publié: (2021) -
Cranial morphology of Deudorix isocrates (Fab.) (Lepidoptera: Lycaenidae) larvae
par: Ravindrakumar D. Patil, et autres
Publié: (2021) -
Production of antibody fragment (Fab) throughout Escherichia coli fed-batch fermentation process: Changes in titre, location and form of product
par: Jalalirad,Reza
Publié: (2013)